O

Oric Pharmaceuticals
D

ORIC

7.68000
USD
0.19
(2.54%)
مغلق
حجم التداول
43,490
الربح لكل سهم
-2
العائد الربحي
-
P/E
-4
حجم السوق
545,486,016
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    F
    FULC
    -0.00500
    (-0.13%)
    3.85000 USD
    G
    GH
    -4.510
    (-9.51%)
    42.910 USD
    S
    SG
    -1.674
    (-7.12%)
    21.830 USD
    S
    STRA
    -2.090
    (-2.02%)
    101.570 USD
    V
    VCYT
    -1.820
    (-4.43%)
    39.230 USD
    المزيد
الأخبار
المقالات

العنوان: Oric Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.